Neutrophils in the innate immunity conundrum of cystic fibrosis: A CFTR-related matter?

Journal of Innate Immunity

Volumn 5, Issue 3, 2013, Pages 195-196

  Witko Sarsat, Véronique ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; OXIDIZING AGENT;

APOPTOSIS; BACTERIAL IMMUNITY; BONE MARROW CELL; CELL PHAGOCYTOSIS; CYSTIC FIBROSIS; EDITORIAL; GENE MUTATION; HETEROZYGOTE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; INNATE IMMUNITY; NEUTROPHIL; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA;

EID: 84875686631     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000350215     Document Type: Editorial

References (13)

1. Cohen TS, Prince A: Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 2012; 18:509-519.
2. Zhou Y, Song K, Painter RG, Aiken M, Reiser J, Stanton BA, Nauseef WM, Wang G: Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutro-phils. J Innate Immun 2013;5:219-230.
3. Painter RG, Valentine VG, Lanson NA Jr, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G, Wang G: CFTR expression in human neutro-phils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 2006; 45:10260-10269.
4. Painter RG, Bonvillain RW, Valentine VG, Lombard GA, LaPlace SG, Nauseef WM, Wang G: The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. J Leukoc Biol 2008; 83:1345-1353.
5. Becq F, Mall MA, Sheppard DN, Conese M, Zegarra-Moran O: Pharmacological therapy for cystic fibrosis: from bench to bedside. J Cyst Fibros 2011; 10(suppl 2):S129-S145.
6. Keiser NW, Engelhardt JF: New animal models of cystic fibrosis: what are they teaching us? Curr Opin Pulm Med 2011; 17:478-483.
7. Su X, Looney MR, Su HE, Lee JW, Song Y, Matthay MA: Role of CFTR expressed by neu-trophils in modulating acute lung inflammation and injury in mice. Inflamm Res 2011; 60: 619-632.
8. Bonfield TL, Hodges CA, Cotton CU, Drumm ML: Absence of the cystic fibrosis transmem-brane regulator (CFTR) from myeloid-de-rived cells slows resolution of inflammation and infection. J Leukoc Biol 2012; 92:1111-1122.
9. Hayes E, Pohl K, McElvaney NG, Reeves EP: The cystic fibrosis neutrophil: a specialized yet potentially defective cell. Arch Immunol Ther Exp (Warsz) 2011; 59:97-112.
10. Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, Lenoir G, Descamps-Latscha B: Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homo-zygotes and heterozygotes, and its correction by amiloride. J Immunol 1996; 157:2728-2735.
11. Moriceau S, Lenoir G, Witko-Sarsat V: In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J Innate Im-mun 2010; 2:260-266.
12. Ollero M, Brouillard F, Edelman A: Cystic fi-brosis enters the proteomics scene: new answers to old questions. Proteomics 2006; 6: 4084-4099.
13. Witko-Sarsat V, Sermet-Gaudelus I, Lenoir G, Descamps-Latscha B: Inflammation and CFTR: might neutrophils be the key in cystic fibrosis? Mediators Inflamm 1999; 8:7-11.